Metabolic and hypoxic adaptation to anti-angiogenic therapy: a target for induced essentiality
about
Overcoming Hypoxia-Mediated Tumor Progression: Combinatorial Approaches Targeting pH Regulation, Angiogenesis and Immune DysfunctionEpidermal growth factor, latrophilin, and seven transmembrane domain-containing protein 1 marker, a novel angiogenesis markerBiomarkers of evasive resistance predict disease progression in cancer patients treated with antiangiogenic therapies.Microenvironmental Targets in SarcomaTargeting carbonic anhydrase IX improves the anti-cancer efficacy of mTOR inhibitorsMonitoring the vascular response and resistance to sunitinib in renal cell carcinoma in vivo with susceptibility contrast MRI.Gold nanoparticles attenuate metastasis by tumor vasculature normalization and epithelial-mesenchymal transition inhibition.In vitro downregulated hypoxia transcriptome is associated with poor prognosis in breast cancer.Combination therapy in combating cancer.Association of Angiopoietin-2 and Ki-67 Expression with Vascular Density and Sunitinib Response in Metastatic Renal Cell Carcinoma.Genomic alterations underlie a pan-cancer metabolic shift associated with tumour hypoxia.EphrinB2 repression through ZEB2 mediates tumour invasion and anti-angiogenic resistance.Lack of R-Ras Leads to Increased Vascular Permeability in Ischemic Retinopathy.The BET inhibitor JQ1 selectively impairs tumour response to hypoxia and downregulates CA9 and angiogenesis in triple negative breast cancer.Antiangiogenic cancer treatment: The great discovery and greater complexity (Review).Arg-Leu-Tyr-Glu tetrapeptide inhibits tumor progression by suppressing angiogenesis and vascular permeability via VEGF receptor-2 antagonism.The diagnostic and prognostic role of liquid-based cytology: are we ready to monitor therapy and resistance?Metabolic Symbiosis Enables Adaptive Resistance to Anti-angiogenic Therapy that Is Dependent on mTOR Signaling.Inhibition of carbonic anhydrase potentiates bevacizumab treatment in cholangiocarcinoma.Methods: Using Three-Dimensional Culture (Spheroids) as an In Vitro Model of Tumour Hypoxia.Manipulating Angiogenesis by Targeting Endothelial Metabolism: Hitting the Engine Rather than the Drivers-A New Perspective?Axl and Mer Receptor Tyrosine Kinases: Distinct and Nonoverlapping Roles in Inflammation and Cancer?Hypoxia and antitumor CD8+ T cells: An incompatible alliance?Self-renewal molecular mechanisms of colorectal cancer stem cells.Roles of RUNX in Hypoxia-Induced Responses and Angiogenesis.Trimming the Vascular Tree in Tumors: Metabolic and Immune Adaptations.The EGLN-HIF O2-Sensing System: Multiple Inputs and Feedbacks.Fine-Tuning Tumor Endothelial Cells to Selectively Kill Cancer.Commentary: A Metabolic Immune Checkpoint: Adenosine in Tumor Microenvironment.Identification of functional metabolic biomarkers from lung cancer patient serum using PEP technology.HIGD1A-mediated dormancy and tumor survival.A ketogenic diet supplemented with medium-chain triglycerides enhances the anti-tumor and anti-angiogenic efficacy of chemotherapy on neuroblastoma xenografts in a CD1-nu mouse model.Metabolic alterations underlying Bevacizumab therapy in glioblastoma cells.Enhancement of the anti-tumor activity of FGFR1 inhibition in squamous cell lung cancer by targeting downstream signaling involved in glucose metabolism.HIF-1α- Targeting Acriflavine Provides Long Term Survival and Radiological Tumor Response in Brain Cancer Therapy.Targeting bromodomain and extraterminal proteins in breast cancer.Monocarboxylate transporter 1 is a key player in glioma-endothelial cell crosstalk.Non-invasive monitoring of the therapeutic response in sorafenib-treated hepatocellular carcinoma based on photoacoustic imaging.Contribution of Adipose Tissue to Development of Cancer.Cancer Associated Fibroblasts: The Architects of Stroma Remodeling.
P2860
Q26749333-E47B02BC-D0E3-44C2-A718-08DBBE20CA97Q26771513-F04AE3AD-5274-4F50-BE74-3512E401B792Q27853358-004F5FA3-F030-4A3E-A46F-D09E1E2DEC13Q28081400-76528E6D-9608-4FDE-A0F3-16CE77C1B6B8Q28822228-ADBB1EAF-66A6-4A57-AFA1-0B629046D76AQ32176092-AB429C9C-F909-494D-AA74-4248FB7CECECQ33650400-22D73BB3-7C15-42DD-B890-E6D91D38CE74Q33805335-C3DD3633-F2C6-4C4B-B93A-48D7ECD2E12EQ33914234-AEB30D28-A063-4061-8141-D316C4F1AE30Q35995721-92F61A48-D915-446B-9DF0-F85983164409Q37050321-7F43EA46-24A7-415E-94C7-EEB1B0022BC2Q37153834-A142E650-5B28-4C81-AABF-9A51613471F8Q37275313-D8C3C0B6-7BEE-4D48-B6DB-3025DDF6E922Q37333948-95573510-651A-4A50-AE01-58011EFEEC01Q37337814-85FD415C-44A1-4D04-9EEF-865457CB9DF4Q37706985-F8CD3CF3-AA29-4153-8F27-0D5904EE1022Q38552886-881CAC1E-7497-4A4D-BFC2-DC404ED769F9Q38773966-CF099B3A-8ECF-4A56-BFA0-46A176941917Q38804116-F4F9EBFC-BAFB-40F2-93EC-BAF471EFE9C4Q38871432-825916A2-022F-4A54-B972-BB733EC12F57Q38882106-34E75AC5-64C7-4F7B-8F0B-B02879FE1893Q38936702-F361EF0B-D96A-44CC-B2AD-4DE034C4613AQ38998450-4841F641-7047-4EC6-829E-DFB4DE5F1A93Q39026588-F3F7CFE0-4CC0-4F1A-9E1F-7B3C0D1D7964Q39181432-7CCC76FB-A95E-4317-8F52-5942A6A0ADF1Q39232954-07F9257F-FE7D-4A40-9A51-AFF0E2B1C587Q39378738-B3656F09-6DBD-41DA-899B-1F0F2D22CE91Q39406918-E34FB4B7-CD01-45FE-97EB-2227B3BE2EC5Q40985733-26ECE542-C496-4DE8-A15B-7D2CC84C0D0EQ41968203-CC547742-8319-4B6D-B068-0D9DB106305DQ42227940-60E17E79-219F-48FA-8DBE-7A5FB29C3EE7Q42371465-8221FEDA-2D10-4917-89B1-72FAEB177DDBQ47114557-6C82A071-3EB3-4E03-BF74-685F639E7CFCQ47135891-30647F7F-523C-444E-BBED-E825794517B5Q47385937-FC0FE1C6-F6D3-4EFC-91BA-616AB4387C88Q47385983-8A19E984-56FF-46B4-957F-D9072B6653BCQ47859447-EBBF4E5D-9E41-4511-9A11-E5883F9CF83BQ48018285-38A273AE-B88D-450A-88C9-AC4FC682B771Q49164235-2E6F4817-3BA5-4FC5-84BD-CFA4ED20A484Q49561501-B57B0858-8DCD-4CD4-909E-02C63562187A
P2860
Metabolic and hypoxic adaptation to anti-angiogenic therapy: a target for induced essentiality
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Metabolic and hypoxic adaptati ...... arget for induced essentiality
@ast
Metabolic and hypoxic adaptati ...... arget for induced essentiality
@en
Metabolic and hypoxic adaptati ...... arget for induced essentiality
@nl
type
label
Metabolic and hypoxic adaptati ...... arget for induced essentiality
@ast
Metabolic and hypoxic adaptati ...... arget for induced essentiality
@en
Metabolic and hypoxic adaptati ...... arget for induced essentiality
@nl
prefLabel
Metabolic and hypoxic adaptati ...... arget for induced essentiality
@ast
Metabolic and hypoxic adaptati ...... arget for induced essentiality
@en
Metabolic and hypoxic adaptati ...... arget for induced essentiality
@nl
P2860
P921
P3181
P356
P1476
Metabolic and hypoxic adaptati ...... arget for induced essentiality
@en
P2093
A. L. Harris
A. McIntyre
P2860
P304
P3181
P356
10.15252/EMMM.201404271
P407
P5008
P577
2015-04-01T00:00:00Z